Merck KGaA (ETR:MRK) Stock Price Up 0.8% – Time to Buy?

Merck KGaA (ETR:MRK) shares rose 0.8% during mid-day trading on Thursday. The company traded as high as €141.10 and last traded at €140.15. 445,194 shares traded hands during trading, The stock had previously closed at €139.00.

Merck KGaA Stock Performance

The company’s 50 day moving average price is €137.45 and its 200-day moving average price is €129.94. The stock has a market cap of $62.41 billion, a P/E ratio of 23.02, a price-to-earnings-growth ratio of 2.37 and a beta of 0.81. The company has a debt-to-equity ratio of 40.77, a quick ratio of 0.72 and a current ratio of 1.69.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.